RxSight Light Adjustable Lens® Clinical Study

For Cataract Surgery 

Intraocular lenses (IOLs) are lenses designed to reduce the dependence on glasses after routine cataract surgery.

If you have healthy eyes and have been  diagnosed with cataracts, you may qualify for this study that further evaluates an FDA-approved IOL.

Compensation is available for qualifying patients.

Enrollment is limited.

Medicare & most insurance accepted

https://www.rxsight.com/us/clinical-study

RxSight Light Adjustable Lens® Clinical Study

Do you need cataract surgery? If so, you may be eligible to participate in a research study conducted by RxSight to further evaluate an FDA-approved intraocular lens (IOL), the RxSight Light Adjustable Lens (LAL). The LAL allows your doctor to adjust the power of the lens after it has been implanted in your eye to improve distance vision.

Approximately 500 men and women will participate in this study. During this study, patients will have a 66% (2/3) chance of receiving a Light Adjustable Lens, and a 33% (1/3) chance of receiving a commercially available monofocal IOL. Patients will need to return to the doctor’s office for evaluation over a 6-month period.

You may qualify for this study if:

• You are between 40 and 80 years of age

• You currently have a cataract

A formal consent process and eye exam are required before decisions can be made about your enrollment and willingness to be involved with this study.